null

Ifabotuzumab (Anti-EPHA3) Biosimilar Antibody

SKU:
HDBS0019
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
EPHA3
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
  • Anti-EPHA3 ifabotuzumab biosimilar mAb HDBS0019
  • Anti-EPHA3 ifabotuzumab biosimilar mAb HDBS0019
  • Anti-EPHA3 ifabotuzumab biosimilar mAb HDBS0019
€373
Frequently bought together:

Description

system_update_altDatasheet

Ifabotuzumab (Anti-EPHA3) Biosimilar Antibody (HDBS0019)

The Anti-Epha3 (Ifabotuzumab) Biosimilar Mab (HDBS0019) is a monoclonal antibody designed for research involving Epha3, a cell surface receptor known for its role in cell signaling and regulation. This biosimilar antibody, similar to the therapeutic antibody Ifabotuzumab, binds specifically to the Epha3 protein and can be used for various applications such as immunofluorescence, immunohistochemistry, and flow cytometry.Epha3 is a member of the Eph receptor family, which is involved in cell adhesion and migration in various physiological and pathological processes. Dysregulation of Epha3 signaling has been implicated in conditions such as cancer, neurodegenerative diseases, and vascular disorders.

By targeting Epha3 with this biosimilar antibody, researchers can further explore its function and potential therapeutic applications in these disease contexts.The Anti-Epha3 (Ifabotuzumab) Biosimilar Mab (HDBS0019) offers a reliable tool for studying Epha3 biology and its role in cellular processes. With its high specificity and reactivity, this antibody facilitates the detection and analysis of Epha3 expression in various cell types, providing valuable insights for drug development and personalized medicine approaches targeting Epha3-related pathways.